跳至主要内容
临床试验/EUCTR2005-003824-21-GB
EUCTR2005-003824-21-GB进行中(未招募)不适用

Effects and comparisons of once & twice daily insulin’s in combination with oral hypoglycaemic agents on glycaemic control, hypoglycaemia and weight in type 2 Diabetes.

Royal Liverpool University Hospital0 个研究点开始时间: 2007年5月15日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1.Patients with Type 2 Diabetes Mellitus:
  • a.Insulin naïve.
  • b.Men or Women.
  • c.Age between 40-80 years.
  • d.Duration of diabetes of at least 3 years.
  • 2.HbA1c > 7.5%.
  • 3.On maximum tolerated combination oral hypoglycaemic agents for more than 6 months.
  • 4.BMI > 25.
  • 5.All patients clinically requiring the commencement of insulin therapy.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1.Proliferative diabetic retinopathy requiring acute treatment.
  • 2.Acute or chronic Renal failure.
  • 3.Acute or chronic hepatic failure.
  • 4.Severe Cardiac failure.
  • 5.Allergy to insulin.
  • 6.Alcohol dependence.
  • 7.Pregnancy & Breast feeding.
  • 8.Patients who have had ketoacidosis.
  • 9.Previous treatment with insulin.

研究者

相似试验